Serum Biomarkers for Identifying Acute Chest Syndrome Among Patients Who Have Sickle Cell Disease and Present to the Emergency Department
Open Access
- 1 September 2005
- journal article
- Published by American Academy of Pediatrics (AAP)
- Vol. 116 (3) , e420-e425
- https://doi.org/10.1542/peds.2004-2107
Abstract
Objective. To compare the accuracy of biomarkers for identifying acute chest syndrome (ACS) in patients with sickle cell disease presenting to a pediatric emergency department (ED).Keywords
This publication has 15 references indexed in Scilit:
- Inhibition of IL-6 for the treatment of inflammatory diseasesCurrent Opinion in Pharmacology, 2004
- Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell DiseaseNew England Journal of Medicine, 2000
- Mepacrine decreases lung leak in rats given interleukin-1 intratracheally.American Journal of Respiratory and Critical Care Medicine, 1997
- Effect of transfusion in acute chest syndrome of sickle cell diseaseThe Journal of Pediatrics, 1995
- Pathogenesis of Lung Disease in Sickle HemoglobinopathiesAmerican Review of Respiratory Disease, 1993
- Acute Lung Injury Induced by Phospholipase A2: Structural and Functional ChangesAmerican Review of Respiratory Disease, 1991
- Measuring the Accuracy of Diagnostic SystemsScience, 1988
- Beneficial Effect of Blood Transfusion in Children With Sickle Cell Chest SyndromeArchives of Pediatrics & Adolescent Medicine, 1988
- Sickle Cell Chronic Lung DiseaseMedicine, 1988
- The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology, 1982